Evidence map›Paper›PMID 39207558›Full record

ArticleAnnals of hematology2024

Unravelling a KMT2A::ARHGEF12 fusion within chromoanagenesis in acute myeloid leukemia using Optical Genome Mapping.

Corentine Klos, Pauline Roynard, Céline Berthon, Valérie Soenen, Alice Marceau, Elise Fournier, Laurene Fenwarth, Agnès Daudignon, Catherine Roche, Hélène Guermouche

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of hematology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Corentine KlosCHU Lille, Institute of Medical Genetics, Jeanne de Flandre Hospital, Avenue Eugène Avinée, 59037, Lille Cedex, France.
Pauline RoynardCHU Lille, Institute of Medical Genetics, Jeanne de Flandre Hospital, Avenue Eugène Avinée, 59037, Lille Cedex, France.
Céline BerthonHematology Department, CHU Lille, Lille, France.
Valérie SoenenLaboratory of Hematology, CHU Lille, Lille, France.
Alice MarceauLaboratory of Hematology, CHU Lille, Lille, France.
Elise FournierLaboratory of Hematology, CHU Lille, Lille, France.
Laurene FenwarthPlasticity and Resistance to Therapies, University of Lille, CNRS, Inserm, CHU Lille, IRCL, UMR9020 - UMR1277 - Canther - Cancer Heterogeneity, Lille, France.
Agnès DaudignonCHU Lille, Institute of Medical Genetics, Jeanne de Flandre Hospital, Avenue Eugène Avinée, 59037, Lille Cedex, France.
Catherine RocheCHU Lille, Institute of Medical Genetics, Jeanne de Flandre Hospital, Avenue Eugène Avinée, 59037, Lille Cedex, France.
Hélène GuermoucheCHU Lille, Institute of Medical Genetics, Jeanne de Flandre Hospital, Avenue Eugène Avinée, 59037, Lille Cedex, France. helene.guermouche@chu-lille.fr.ORCID http://orcid.org/0000-0003-4074-1623

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Acute myeloid leukemiaChromoanagenesisKMT2A::ARHGEF12Optical genome mapping

Identifiers

PMID39207558
PMCPMC11534995

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.